AMY KINZIE: Open Payments
NPI 1053725168 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 13 payments from 7 companies in 2025. Trend: 2023 $216 · 2024 $879 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $407 |
| Novo Nordisk Inc | 4 | $287 |
| Incyte Corporation | 1 | $125 |
| CSL Behring | 1 | $75 |
| SOBI, INC | 1 | $27 |
| Chiesi USA, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
Products named: QFITLIA, Alhemo, Niktimvo, HEMGENIX, ALTUVIIIO, Doptelet, FERRIPROX, EPKINLY.
Industry payments across LA — which companies pay providers there.
